CYP19A1 and Alzheimer disease: We further show that treatment of wild-type hippocampal primary cultures with the aromatase inhibitor, letrozole, also leads to glial cell hypertrophy and activation, suggesting that early changes in microglia and astrocytes may contribute to the progression of AD under conditions of local estrogen deficiency.